Market Value2,984,124,707
Total Holdings88
File Date2023-02-14
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
ACAD / ACADIA Pharmaceuticals Inc.
ALEC / Alector, Inc.
ALXO / ALX Oncology Holdings Inc.
ITOS / iTeos Therapeutics, Inc.
MRTX / Mirati Therapeutics, Inc.
TVTX / Travere Therapeutics, Inc.
GMED / Globus Medical, Inc.
CRNX / Crinetics Pharmaceuticals, Inc.
ENTA / Enanta Pharmaceuticals, Inc.
ARGX / argenx SE - Depositary Receipt (Common Stock)
IMTX / Immatics N.V.
DBVT / DBV Technologies S.A. - Depositary Receipt (Common Stock)
CMPX / Compass Therapeutics, Inc.
XENE / Xenon Pharmaceuticals Inc.
PEN / Penumbra, Inc.
NKTR / Nektar Therapeutics
PCVX / Vaxcyte, Inc.
/ Fusion Networks Holdings, Inc.
US670704AL95 / NuVasive Inc
US868459AD01 / Supernus Pharmaceuticals Inc Bond
US761299AB20 / Retrophin Inc Bond
US46185LAB99 / Invitae Corp
US63009RAD17 / NanoString Technologies Inc
US670704AJ40 / NuVasive, Inc.
US09061GAH48 / BioMarin Pharmaceutical, Inc. Bond
US03236MAJ09 / Amyris Inc
US462222AD25 / Ionis Pharmaceuticals Inc
US48576UAA43 / Karyopharm Therapeutics Inc
US64157FAC77 / Nevro Corp
US64049MAA80 / NeoGenomics Inc
US457669AB50 / INSMED INC CONV 0.75% 06/01/2028
US30063PAB13 / Exas 3/8 3/15/27 Bond
US89422GAA58 / Travere Therapeutics, Inc.
US30063PAC95 / EXACT SCIENCES CORP CONV 0.375% 03/01/2028
US457669AA77 / Insmed Inc Bond
US462222AB68 / Ionis Pharmaceuticals Inc
US09061GAK76 / CONV. NOTE
KIDS / OrthoPediatrics Corp.
VRDN / Viridian Therapeutics, Inc.
RAPT / RAPT Therapeutics, Inc.
MIST / Milestone Pharmaceuticals Inc.
BLU / Bellus Health Inc
US64049MAB63 / NeoGenomics Inc
NVCR / NovoCure Limited
US40131MAB54 / CONVERTIBLE ZERO
US10806XAD49 / BRIDGEBIO PHARMA INC
MRSN / Mersana Therapeutics, Inc.
NTRA / Natera, Inc.
SNDX / Syndax Pharmaceuticals, Inc.
AMGN / Amgen Inc.
QDEL / QuidelOrtho Corporation
IRTC / iRhythm Technologies, Inc.
COO / The Cooper Companies, Inc.
SILK / Silk Road Medical, Inc
EW / Edwards Lifesciences Corporation
IMGN / ImmunoGen, Inc.
MLTX / MoonLake Immunotherapeutics
ALLK / Allakos Inc.
US10806XAB82 / Bridgebio Pharma, Inc.
NUVB / Nuvation Bio Inc.
PTGX / Protagonist Therapeutics, Inc.
OM / Outset Medical, Inc.
NKTX / Nkarta, Inc.
BIIB / Biogen Inc.
STE / STERIS plc
DICE / DICE Therapeutics Inc
ISRG / Intuitive Surgical, Inc.
ISEE / IVERIC bio Inc
ACRS / Aclaris Therapeutics, Inc.
ESPR / Esperion Therapeutics, Inc.
KOD / Kodiak Sciences Inc.
DYN / Dyne Therapeutics, Inc.
LUNG / Pulmonx Corporation
GKOS / Glaukos Corporation
DAWN / Day One Biopharmaceuticals, Inc.
ALGN / Align Technology, Inc.
KRYS / Krystal Biotech, Inc.
US02081GAB86 / Alphatec Holdings, Inc.
ANAB / AnaptysBio, Inc.
REPL / Replimune Group, Inc.
HLVX / HilleVax, Inc.
DCPH / Deciphera Pharmaceuticals, Inc.
MRUS / Merus N.V.
SRPT / Sarepta Therapeutics, Inc.
LEGN / Legend Biotech Corporation - Depositary Receipt (Common Stock)
TMDX / TransMedics Group, Inc.
APLS / Apellis Pharmaceuticals, Inc.
NVRO / Nevro Corp.